PATENT CLAIM ANALYSIS

Application Number: 16149913
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["560", "124000"]

Abstract:
A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising a compound set forth in Formula (I):

Claim (Index 7):
The method of  claim 4  further comprising administering to the individual a second agent selected from the group consisting of Omega 3 oil, salicylic acid, dimethylbutanol, garlic oil, olive oil, krill oil, Co enzyme Q-10, a probiotic, a prebiotic, dietary fiber,  psyllium  husk, bismuth salts, phytosterols, grape seed oil, green tea extract, vitamin D, an antioxidant, turmeric, curcumin, and resveratrol.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 97.0
- Lexical Diversity: 1.17241
- Patent Class: 560.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15366940', '14866398', '15605437', '13915299', '13363661']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.706381131495066
- 35 USC 102 Novelty (BERT): 0.5642838945958979
- Combined Prediction Score: 0.6921714078051492
- Mean Citation Score: 245.85887
- Max Citation Score: 376.33347
- Similarity Product: 292.0030187221098

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test